A combination of mirtazapine and milnacipran augments the extracellular levels of monoamines in the rat brain

Neuropharmacology

Volumn 62, Issue 7, 2012, Pages 2278-2287

  Yamauchi, Miki ^a   Imanishi, Taiichiro ^a   Koyama, Tsukasa ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine; Microdialysis; Milnacipran; Mirtazapine; Noradrenaline; Serotonin

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE; IDAZOXAN; KETANSERIN; MILNACIPRAN; MIRTAZAPINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEROTONINERGIC TRANSMISSION;

EID: 84859109814     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.01.024     Document Type: Article

References (43)

1. S.H. Abbasi, H. Behpournia, A. Ghoreshi, B. Salehi, M. Raznahan, S.A. Rezazadeh, F. Rezaei, and S. Akhondzadeh The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial Schizophr. Res. 116 2010 101 106
2. K.D. Alex, and E.A. Pehek Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission Pharmacol. Ther. 113 2007 296 320 (Pubitemid 46149046)
3. M.B. Assie, M. Charveron, C. Palmier, C. Puozzo, C. Moret, and M. Briley Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat Neuropharmacology 31 1992 149 155
4. J.M. Baraban, and G.K. Aghajanian Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists Neuropharmacology 19 1980 355 363 (Pubitemid 10095684)
5. 2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo Naunyn Schmiedebergs Arch. Pharmacol. 362 2000 406 412
6. P. Blier, H.E. Ward, P. Tremblay, L. Laberge, C. Hebert, and R. Bergeron Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study Am. J. Psychiatry 167 2010 281 288
7. M. Briley Specific serotonin and noradrenaline reuptake inhibitors (SNRIs). A review of their pharmacology, clinical efficacy and tolerability Hum. Psychopharmacol. 13 1998 99 111 (Pubitemid 28138898)
8. E. Carboni, and A. Silvagni Dopamine reuptake by norepinephrine neurons: exception or rule? Crit. Rev. Neurobiol. 16 2004 121 128 (Pubitemid 39586910)
9. J.M. Casanovas, and F. Artigas Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways J. Neurochem. 67 1996 1945 1952 (Pubitemid 26349667)
10. K.R. Connolly, and M.E. Thase If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies Drugs 71 2011 43 64
11. T. de Boer The pharmacologic profile of mirtazapine J. Clin. Psychiatry 57 Suppl. 4 1996 19 25 (Pubitemid 26177340)
12. T.H. de Boer, F. Nefkens, A. van Helvoirt, and A.M. van Delft Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan J. Pharmacol. Exp. Ther. 277 1996 852 860 (Pubitemid 27168997)
13. P. Devoto, and G. Flore On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? Curr. Neuropharmacol. 4 2006 115 125
14. P. Devoto, G. Flore, L. Pira, G. Longu, and G.L. Gessa Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex Eur. J. Pharmacol. 487 2004 105 111 (Pubitemid 38368986)
15. M. El Mansari, B.P. Guiard, O. Chernoloz, R. Ghanbari, N. Katz, and P. Blier Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder CNS Neurosci. Ther. 16 2010 e1 17
16. E. Esposito Serotonin-dopamine interaction as a focus of novel antidepressant drugs Curr. Drug Targets 7 2006 177 185
17. 2-Adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats J. Neurochem. 69 1997 2616 2619 (Pubitemid 27495451)
18. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat Synapse 36 2000 205 221 (Pubitemid 30252995)
19. 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission Naunyn Schmiedebergs Arch. Pharmacol. 355 1997 20 29 (Pubitemid 27008448)
20. 2C receptor antagonist Neuropharmacology 36 1997 609 620 (Pubitemid 27272106)
21. Y. Kitaichi, T. Inoue, T. Izumi, S. Nakagawa, A. Kato, and T. Koyama Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats Eur. J. Pharmacol. 520 2005 37 42 (Pubitemid 41375809)
22. Y. Kitaichi, T. Inoue, S. Nakagawa, T. Izumi, and T. Koyama Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium Eur. J. Pharmacol. 516 2005 219 226 (Pubitemid 40922741)
23. 2A receptor occupancy Eur. J. Pharmacol. 591 2008 136 141
24. A.J. Loonen, C.H. Doorschot, M.C. Oostelbos, and J.M. Sitsen Lack of drug interactions between mirtazapine and risperidone in psychiatric patients: a pilot study Eur. Neuropsychopharmacol. 10 1999 51 57
25. G.S. Malhi, F. Ng, and M. Berk Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression Aust. N. Z. J. Psychiatry 42 2008 346 349 (Pubitemid 351386496)
26. R. McQuade, and T. Sharp Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis J. Neurochem. 69 1997 791 796 (Pubitemid 27327983)
27. 2C receptors: a comparison with citalopram Eur. J. Neurosci. 12 2000 1079 1095 (Pubitemid 30168787)
28. 1A receptor activation Brain Res. Bull. 63 2004 237 241 (Pubitemid 38622580)
29. D.J. Nutt Tolerability and safety aspects of mirtazapine Hum. Psychopharmacol. 17 Suppl. 1 2002 S37 S41
30. F.E. O'Brien, T.G. Dinan, B.T. Griffin, and J.F. Cryan Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings Br. J. Pharmacol. 165 2012 289 312
31. Ogawa, Y., Osada, K., Haga, T., Nakano, M., Matsui, H., Asakura, M., Yamaguchi, N., 2010. Milnacipran was a substrate for P-glycoprotein in the hippocampal neuronal in vitro system of HT22 cells. In: 40th Annual Meeting of the Society for Neuroscience.
32. N.K. Ozmenler, T. Karlidere, A. Bozkurt, S. Yetkin, A. Doruk, L. Sutcigil, A. Cansever, O. Uzun, F. Ozgen, and A. Ozsahin Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors Hum. Psychopharmacol. 23 2008 321 326 (Pubitemid 351982669)
33. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press, Inc. San Diego
34. C. Puozzo, E. Panconi, and D. Deprez Pharmacology and pharmacokinetics of milnacipran Int. Clin. Psychopharmacol. 17 Suppl. 1 2002 S25 S35
35. S. Rigucci, G. Serafini, M. Pompili, G.D. Kotzalidis, and R. Tatarelli Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies World J. Biol. Psychiatry 11 2010 165 180
36. J.E. Rojo, S. Ros, L. Aguera, J. de la Gandara, and J.M. de Pedro Combined antidepressants: clinical experience Acta Psychiatr. Scand. Suppl. 428 2005 25 31 (Pubitemid 41789708)
37. 1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors J. Neurochem. 68 1997 2593 2603 (Pubitemid 27218184)
38. 2C receptor blockade-induced augmentation of SSRIs effects Neuropharmacology 57 2009 18 24
39. S.M. Stahl Essential Psychopharmacology: Neuroscientific Basis and Practical Applications third ed. 2008 Cambridge University Press New York
40. A. Szegedi, and N. Schwertfeger Mirtazapine: a review of its clinical efficacy and tolerability Expert Opin. Pharmacother. 6 2005 631 641 (Pubitemid 40613889)
41. K. Tachibana, M. Matsumoto, H. Koseki, H. Togashi, T. Kojima, Y. Morimoto, and M. Yoshioka Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems J. Psychopharmacol. 20 2006 562 569 (Pubitemid 43875186)
42. 2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus J. Psychopharmacol. 18 2004 395 403 (Pubitemid 39382568)
43. S. Yamamura, M. Abe, M. Nakagawa, S. Ochi, S. Ueno, and M. Okada Different actions for acute and chronic administration of mirtazapine on serotonergic transmission associated with raphe nuclei and their innervation cortical regions Neuropharmacology 60 2011 550 560